News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Syneron Medical Cuts IPO Price Range To $12-$13 A Share From $14-$16
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Underwriters for Syneron Medical Ltd., a provider of tools for use in non-invasive aesthetic medical procedures, have cut the estimated price range for the company's pending initial public offering to $12 to $13 a share from $14 to $16 a share.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Deals
Novartis bets up to $7.8B for an mRNA-encoded T cell engager from China’s Abogen
October 2, 2026
·
2 min read
·
Tristan Manalac
Immunology and inflammation
Sanofi pays Regeneron $1B upfront to continue search for Dupixent successor
October 1, 2026
·
3 min read
·
Tristan Manalac
Manufacturing
BioNTech to close German manufacturing plants after failing to find buyers
September 30, 2026
·
2 min read
·
Nick Paul Taylor
Business
Summit snags $2B investment from AstraZeneca, clearing financial overhang
September 29, 2026
·
3 min read
·
Tristan Manalac
